http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007142757-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7da1b93546c6fc0373f9d74754ee714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3877636f5ff3b037637a1fd91a1f2f30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b12632c93bec895c993134dd04f3868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db8be9c2467ddb5b04ca5defeb002f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b369f5a06ee4c1771d6754e55abbd6cd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0061
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
filingDate 2007-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b994f529c0c560190be21e23db11de5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5450517c16b1ceffe0cbc63c146b796a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b0b1a935837278377053ca26be710f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80c552d86e3eed56c34b502925ab0c03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd1675c84189647e13e42157d7c7b92
publicationDate 2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007142757-A3
titleOfInvention Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions
abstract Compositions which self-assemble under physiological conditions are formulate for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may als include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer. The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatme such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination wit an oil and forms a laminate. In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent.
priorityDate 2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9509659-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03084980-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006025524-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 34.